Randi Hagerman
Medical Director
MIND Institute
From this contributor
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Drug trials for fragile X syndrome lead the way for autism
Several targeted trials on drugs that treat fragile X syndrome are under way. But accurate endpoints to measure the drugs’ effectiveness are crucial, argues developmental and behavioral pediatrician Randi Hagerman.
Drug trials for fragile X syndrome lead the way for autism
Explore more from The Transmitter
AI-assisted coding: 10 simple rules to maintain scientific rigor
These guidelines can help researchers ensure the integrity of their work while accelerating progress on important scientific questions.
AI-assisted coding: 10 simple rules to maintain scientific rigor
These guidelines can help researchers ensure the integrity of their work while accelerating progress on important scientific questions.
Glutamate receptors, mRNA transcripts and SYNGAP1; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 December.
Glutamate receptors, mRNA transcripts and SYNGAP1; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 December.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.